about
Cardiovascular magnetic resonance in systemic hypertensionElectrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers.Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function.Characterization of the ultrashort-TE (UTE) MR collagen signal.Atrial electromechanical delay in patients undergoing heart transplantation.Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase.Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trialA Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling.Diastolic heart failure. Paroxysmal or chronic?Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.Hypertensive myocardial fibrosis.Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing miceECM remodeling in hypertensive heart disease.Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.Fibrosis and heart failure.Myofibroblast-mediated mechanisms of pathological remodelling of the heart.Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.Persistent change in cardiac fibroblast physiology after transient ACE inhibition.Insights from Cardiac Mechanics after Three Decades from Successfully Repaired Aortic Coarctation.Atrophic cardiomyocyte signaling in hypertensive heart diseaseAdenylyl cyclase activity and function are decreased in rat cardiac fibroblasts after myocardial infarction.Fragmented QRS complexes are associated with increased left ventricular mass in patients with essential hypertension.Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.Aortic dissection and third-degree atrioventricular block in a patient with a hypertensive crisis.The relationship between fragmented QRS and non-dipper status in hypertensive patients without left ventricular hypertrophy.The interplay between renin-angiotensin system activation, abnormal myocardial deformation and neurohumoral activation in hypertensive heart disease: a speckle tracking echocardiography study.In vivo quantification of myocardial stiffness in hypertensive porcine hearts using MR elastography.Myocardial functional and textural findings of the right and left ventricles and their association with cellular adhesion molecules in Behçet's disease.Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy.Structural alterations in rat myocardium induced by chronic l-arginine and l-NAME supplementation.Clinical implications of apoptosis in hypertensive heart disease
P2860
Q30466693-7CC5B06A-3EAF-445D-B4CC-D5760E7ECF11Q30484110-2A8D1DB5-ED70-4174-BCF0-35100FDF51F8Q30513942-5B58A775-293D-4A35-98E6-3A8511063721Q30987017-FBA5B2FF-5302-4F83-B3E2-941BB8ED4DE9Q33552987-070288EA-5D9E-4208-B98B-58CEEFCADC37Q33723868-EEA45F59-5E1C-4300-87D6-30FD79C5ADF5Q35252620-5A76B5E1-ADED-40F2-9320-80D2DEA1DA81Q35761216-51D96DCA-28FE-42A6-AA50-6525BFE43D0DQ35795481-44FF905F-9EC0-45CB-99EA-B5624656FC33Q36163634-1352E153-6419-4BAE-A137-FEF2D3CDB07BQ36281111-21DA0298-F9B6-4C19-8673-849BDF312257Q36303503-08013338-0943-43FD-B980-79E5F5A047A8Q36404982-CAC44813-7B3F-4359-90F9-0672816D6438Q36749281-332DEF71-B106-450E-8460-295BE80338BAQ37924999-833004EF-5564-4FDF-8834-BE5AFE748CC8Q38057701-B8F33554-2AB9-48CD-B7A7-354A551B1ED2Q38064729-6015D54C-CEA2-4835-BB7F-2F14FF3F1A3BQ38584976-47C75AE4-F079-4701-8A9A-F041EA4D83C4Q38963920-1EEC6BCB-5CA4-42C4-B7DE-6F5B6CAC817CQ40337674-93EC6EDC-3D77-4423-966D-8E54AA2E2DC9Q41852121-70DE08E1-F455-422D-9799-F1EFB1AD7B68Q42518884-2BA8F4C7-0893-4F8C-8DA3-D2F5B12D8BA6Q45331730-54BAEE94-A0BA-4052-BA47-2123F2E60C0AQ46452148-950660D0-3759-4860-AEBE-BF16C66158C0Q46823654-899AA392-F164-4BE2-8688-D7E51C1F308EQ47715439-E52BABED-5A1A-4933-B079-7846D9995907Q48455995-D221C7ED-3C57-45A8-BD32-6954FA42367DQ51183824-679F3C35-6E10-43B5-9853-B831328E8C68Q51909847-F449B79A-D216-4D51-88B8-0817DE795CD4Q52558432-5359F1F2-396F-4A9E-8BFD-5ACA37ADEDAFQ55154166-542CF891-DCB6-4F11-BF6A-E2F1CF594A39Q57395355-C98B95AE-97AD-4425-BA77-CD8B58209774
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical aspects of hypertensive myocardial fibrosis.
@ast
Clinical aspects of hypertensive myocardial fibrosis.
@en
Clinical aspects of hypertensive myocardial fibrosis.
@nl
type
label
Clinical aspects of hypertensive myocardial fibrosis.
@ast
Clinical aspects of hypertensive myocardial fibrosis.
@en
Clinical aspects of hypertensive myocardial fibrosis.
@nl
prefLabel
Clinical aspects of hypertensive myocardial fibrosis.
@ast
Clinical aspects of hypertensive myocardial fibrosis.
@en
Clinical aspects of hypertensive myocardial fibrosis.
@nl
P1476
Clinical aspects of hypertensive myocardial fibrosis.
@en
P2093
González A
Querejeta R
P304
P356
10.1097/00001573-200111000-00003
P577
2001-11-01T00:00:00Z